Embecta Q3 revenues down 4.8%; adjusted EPS up, guidance raised

Embecta Corp.

2024-Q3 EPS reported $1.10 revenue$837,000,000

Q3 revenues $272.5M, down 4.8% YoY; U.S. down 6.7%, international down 2.5% reported.
Adjusted net income $43.0M ($0.74 diluted) vs $39.8M ($0.69) YoY; adj. EBITDA margin 36.4%.
Raised FY2024 outlook: adjusted EPS now $2.30-$2.35 (prev $2.20-$2.30), adj. gross margin 65.25%-65.50%.
Board declared $0.15 quarterly dividend, payable Sept 13, 2024 to holders of record Aug 27.
Progress on FDA 510(k) for open-loop patch pump; ~93% of global revenue now on own systems.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.